Warning: The NCBI web site requires JavaScript to function. more...
A national physician survey on prescribing syringes as an HIV prevention measure.
Macalino GE, Sachdev DD, Rich JD, Becker C, Tan LJ, Beletsky L, Burris S.
Subst Abuse Treat Prev Policy. 2009 Jun 8;4:13.
Related citations
Access to sterile syringes in Maine: pharmacy practice after the 1993 repeal of the syringe prescription law.
Case P, Beckett GA, Jones TS.
J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S94-101.
Prescribing syringes to prevent HIV: a survey of infectious disease and addiction medicine physicians in Rhode Island.
Rich JD, Whitlock TL, Towe CW, McKenzie M, Runarsdottir V, Aboagye-Kumi M, Burris S.
Subst Use Misuse. 2001 Apr;36(5):535-50.
Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.
Wright-De Agüero L, Weinstein B, Jones TS, Miles J.
J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S102-10.
Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island.
Rich JD, Martin EG, Macalino GE, Paul RV, McNamara S, Taylor LE.
J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S58-61.
A syringe prescription program to prevent infectious disease and improve health of injection drug users.
Rich JD, McKenzie M, Macalino GE, Taylor LE, Sanford-Colby S, Wolf F, McNamara S, Mehrotra M, Stein MD.
J Urban Health. 2004 Mar;81(1):122-34.
New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access.
Coffin PO, Linas BP, Factor SH, Vlahov D.
J Urban Health. 2000 Dec;77(4):781-93.
Syringe distribution to injection drug users for prevention of HIV infection: opinions and practices of health care providers in New York City.
Coffin PO, Fuller C, Blaney S, Vadnai L, Miller S, Vlahov D.
Clin Infect Dis. 2004 Feb 1;38(3):438-41. Epub 2004 Jan 13.
Would you consider prescribing syringes to injection drug users? Addiction Medicine Conference Survey.
Taylor LE, Runarsdottir V, Zampi A, Osei A, Sanford S, Macalino G, McKenzie M, Burris S, Gross JD, Reinert SE, Rich JD.
J Addict Dis. 2003;22(1):67-78.
Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI.
Zaller N, Jeronimo A, Bratberg J, Case P, Rich JD.
J Urban Health. 2010 Dec;87(6):942-53.
Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia.
Vorobjov S, Uusküla A, Abel-Ollo K, Talu A, Jarlais DD.
J Urban Health. 2009 Nov;86(6):918-28. Epub 2009 Nov 18.
Arrests and incarceration of injection drug users for syringe possession in Massachusetts: implications for HIV prevention.
Case P, Meehan T, Jones TS.
J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S71-5.
A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution?
Lurie P, Jones TS, Foley J.
J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S45-51.
The legal environment impeding access to sterile syringes and needles: the conflict between law enforcement and public health.
Gostin LO.
J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S60-70.
The legality of selling or giving syringes to injection drug users.
Burris S, Vernick JS, Ditzler A, Strathdee S.
J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S13-8.
Injection drug users report good access to pharmacy sale of syringes.
Reich W, Compton WM, Horton JC, Cottler LB, Cunningham-Williams RM, Booth R, Singer M, Leukefeld C, Fink J, Stopka TJ, Corsi KF, Tindall MS.
J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S68-72.
Injection and syringe sharing among HIV-infected injection drug users: implications for prevention of HIV transmission. Supplement to HIV/AIDS Surveillance Group.
Diaz T, Chu SY, Weinstein B, Mokotoff E, Jones TS.
J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S76-81.
Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999.
Cotten-Oldenburg NU, Carr P, DeBoer JM, Collison EK, Novotny G.
J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):183-92.
Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US.
Taussig JA, Weinstein B, Burris S, Jones TS.
AIDS. 2000 Jun;14 Suppl 1:S47-51.
Pharmacy student knowledge, attitudes, and beliefs about selling syringes to injection drug users.
Blumenthal WJ, Springer KW, Jones TS, Sterk CE.
J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S34-9.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on